Hepatocyte Transplantation for Inherited Factor VII Deficiency
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Hepatocyte transplantation has been investigated in patients with liver-based metabolic disorders and acute liver failure. We report the first use of hepatocyte transplantation in two brothers with severe inherited coagulation factor VII deficiency. Patient 1 received a total of 1.09x10(9) cryopreserved hepatocytes, and patient received 2.18x10(9) fresh and cryopreserved hepatocytes through a Hickman line inserted in the inferior mesenteric vein. Infusion of isolated human hepatocytes improved the coagulation defect and markedly decreased the requirement for exogenous recombinant factor VII (rFVIIa) to approximately 20% of that before cell transplantation. In both patients, episodes of line sepsis were associated with an increase in rFVIIa requirement. Six months posthepatocyte transplantation, higher rFVIIa doses were required, suggesting loss of transplanted hepatocyte function. Because of increasing problems with venous access and long-term uncertainty of the efficacy of hepatocyte transplantation, orthotopic liver transplantation was performed successfully in both cases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Treatment of the Crigler–Najjar Syndrome Type I with Hepatocyte Transplantation
Fox, I. J., Chowdhury, J. R., Kaufman, S. S., Goertzen, T. C., Chowdhury, N. R., Warkentin, P. I., Dorko, K., Sauter, B. V., & Strom, S. C. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805143382004 · Cited by 1,023
Hepatocyte transplantation as a treatment for glycogen storage disease type 1a
Muraca, M., Gerunda, G., Neri, D., Vilei, M.-T., Granato, A., Feltracco, P., Meroni, M., Giron, G., & Burlina, A. B. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07529-3 · Cited by 383
Hepatocyte Transplantation for the Treatment of Human Disease
Strom, S., Chowdhury, J., & Fox, I. (1999) · Seminars in Liver Disease · doi:10.1055/s-2007-1007096 · Cited by 366
Hepatic response to sepsis: Interaction between coagulation and inflammatory processes
Dhainaut, J.-F., Marin, N., Mignon, A., & Vinsonneau, C. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107001-00016 · Cited by 361
Isolated Hepatocyte Transplantation in an Infant With a Severe Urea Cycle Disorder
Horslen, S. P., McCowan, T. C., Goertzen, T. C., Warkentin, P. I., Cai, H. B., Strom, S. C., & Fox, I. J. (2003) · Pediatrics · doi:10.1542/peds.111.6.1262 · Cited by 295
Perry, D. J. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03545.x · Cited by 216
De Vree, J. M. L., Ottenhoff, R., Bosma, P. J., Smith, A. J., Aten, J., & Oude Elferink, R. P. J. (2000) · Gastroenterology · doi:10.1053/gast.2000.20222 · Cited by 186 · cited 1×
“With hepatocyte replacement in FVII deficiency, there is no selective advantage for the transplanted hepatocytes to repopulate the otherwise healthy host liver as has been seen with cell transplantation in the rat model of Wilson’s disease (13) and the mouse model of progressive familial intrahepatic cholestasis (14),…”
BackgroundMitry, R. R., Dhawan, A. K., Hughes, R. D., Bansal, S., Lehec, S. C., Terry, C., Heaton, N. D., Karani, J. B., Mieli‐Vergani, G., & Rela, M. (2004) · Transplantation · doi:10.1097/01.tp.0000122224.98318.19 · Cited by 131
Self-citationYoshida, Y., Tokusashi, Y., Lee, G., & Ogawa, K. (1996) · Gastroenterology · doi:10.1016/s0016-5085(96)70029-x · Cited by 122
Horslen, S. P., & Fox, I. J. (2004) · Transplantation · doi:10.1097/01.tp.0000113809.53415.c2 · Cited by 119
Human Hepatocyte Isolation and Relationship of Cell Viability to Early Graft Function
Mitry, R. R., Hughes, R. D., Aw, M. M., Terry, C., Mieli-Vergani, G., Girlanda, R., Muiesan, P., Rela, M., Heaton, N. D., & Dhawan, A. (2003) · Cell Transplantation · doi:10.3727/000000003783985197 · Cited by 113
Self-citation
Cited by
Engineering functional two- and three-dimensional liver systems in vivo using hepatic tissue sheets
Ohashi, K., Yokoyama, T., Yamato, M., Kuge, H., Kanehiro, H., Tsutsumi, M., Amanuma, T., Iwata, H., Yang, J., Okano, T., et al. (2007) · Nature Medicine · doi:10.1038/nm1576 · Cited by 507
Human Hepatocyte Transplantation: Worldwide Results
Fisher, R. A., & Strom, S. C. (2006) · Transplantation · doi:10.1097/01.tp.0000231689.44266.ac · Cited by 445
Decellularized human liver as a natural 3D-scaffold for liver bioengineering and transplantation
Mazza, G., Rombouts, K., Rennie Hall, A., Urbani, L., Vinh Luong, T., Al-Akkad, W., Longato, L., Brown, D., Maghsoudlou, P., Dhillon, A. P., et al. (2015) · Scientific Reports · doi:10.1038/srep13079 · Cited by 415
Knisely, A. S., Strautnieks, S. S., Meier, Y., Stieger, B., Byrne, J. A., Portmann, B. C., Bull, L. N., Pawlikowska, L., Bilezikçi, B., Özçay, F., et al. (2006) · Hepatology · doi:10.1002/hep.21287 · Cited by 379
Self-citationHuman hepatocyte transplantation: current experience and future challenges
Dhawan, A., Puppi, J., Hughes, R. D., & Mitry, R. R. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.44 · Cited by 362
“The combination of tacrolimus (with or without steroids) and monoclonal antibodies, such as interleukin 2 receptor antibodies, has been used in some centers”
MethodSelf-citation
Metadata
- Authors
- Dhawan, A., Mitry, R. R., Hughes, R. D., Lehec, S., Terry, C., Bansal, S., Arya, R., Wade, J. J., Verma, A., Heaton, N. D., Rela, M., & Mieli-Vergani, G.
- Venue
- Transplantation
- Published
- 2004-12
- Volume
- 78
- Issue
- 12
- Pages
- 1812-1814
- ISSN
- 0041-1337 (ISSN-L)
- OpenAlex
- W2033901013
- Cited by
- 262
- References
- 11
- FWCI
- 7.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.